Showing results (41-50 of 63) with videos related to
Sort By:
Pageof 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2007
Plasma, tumor, and tissue disposition of STEALTH liposomal CKD-602 (S-CKD602) and nonliposomal CKD-602 in mice bearing A375 human melanoma xenograftsWilliam C Zamboni, Sandra Strychor, Erin Joseph, et al.Journal of Pharmaceutical and Biomedical Analysis|September 8, 2017
LC-MS/MS assay for the quantitation of the ribonucleotide reductase inhibitor triapine in human plasmaJulia Matsumoto, Brian F Kiesel, Robert A Parise, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 25, 2007
Liquid chromatography-mass spectrometric assay for quantitation of the short-chain fatty acid, 2,2-dimethylbutyrate (NSC 741804), in rat plasmaRobert A Parise, Jan H Beumer, Cyrous O Kangani, et al.Cancer Chemotherapy and Pharmacology|November 17, 2007
Plasma pharmacokinetics and oral bioavailability of 3,4,5,6-tetrahydrouridine, a cytidine deaminase inhibitor, in miceJan H Beumer, Julie L Eiseman, Robert A Parise, et al.Cancer Chemotherapy and Pharmacology|September 1, 2015
Oral and intravenous pharmacokinetics of 5-fluoro-2'-deoxycytidine and THU in cynomolgus monkeys and humansJulianne L Holleran, Jan H Beumer, David L McCormick, et al.Science Translational Medicine|February 14, 2018
Targeting p53-dependent stem cell loss for intestinal chemoprotectionBrian J Leibowitz, Liheng Yang, Liang Wei, et al.Investigational New Drugs|February 5, 2008
Plasma and tissue disposition of non-liposomal DB-67 and liposomal DB-67 in C.B-17 SCID miceWilliam C Zamboni, Laura L Jung, Sandra Strychor, et al.Cancer Chemotherapy and Pharmacology|October 31, 2012
In vitro cytotoxicity, pharmacokinetics, tissue distribution, and metabolism of small-molecule protein kinase D inhibitors, kb-NB142-70 and kb-NB165-09, in mice bearing human cancer xenograftsJianxia Guo, Dana M Clausen, Jan H Beumer, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2005
Plasma pharmacokinetics, oral bioavailability, and interspecies scaling of the DNA methyltransferase inhibitor, zebularineJulianne L Holleran, Robert A Parise, Erin Joseph, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 22, 2004
In vitro metabolism of the phosphatidylinositol 3-kinase inhibitor, wortmannin, by carbonyl reductaseJulianne L Holleran, Julien Fourcade, Merrill J Egorin, et al.Pageof 7